Personalized Movement Training to Help People with PMR Move Better

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study will compare Movement Pattern Training (MoveTrain) to Usual Care in adults with PMR. Researchers will measure pain, daily activity ability, medication use, and muscle strength, and collect patient feedback to see how practical and acceptable MoveTrain is. The trial will also assess the feasibility of conducting a larger study on MoveTrain’s effectiveness. Participants will undergo a detailed, tailored rehabilitation approach aimed at improving movement during everyday tasks. The study emphasizes safety, participant experience, and data on recruitment and adherence for future research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient reports pain \> 3 (0-10, 0 = no pain; 10 = worst pain imaginable)
* Diagnosis or flare of PMR according to the European League against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria as follows (must satisfy all criteria)10:

  * Age ≥50 years at time of diagnosis
  * Presence of bilateral shoulder pain
  * Elevated acute phase reactants C-reactive protein (CRP) \>10 milligram/Liter and/or Erythrocyte Sedimentation Rate (ESR) \>30 millimeters/hour\*
  * A score ≥4 at the time of diagnosis based on the following (without ultrasound):

    * Duration of morning stiffness \>45 minutes: 2 points
    * Hip pain or limited range of motion: 1 point
    * Seronegative for rheumatoid factor and anti-cyclic citrullinated peptide: 2 points
    * Absence of other joint involvement: 1 point
* Able to give informed consent
* Physician's clearance to participate in physical activity

Exclusion Criteria:

* Diagnosis of fibromyalgia, neuropathic muscular disease, complex regional pain syndrome, or small fiber neuropathy
* planned major surgical procedure during the study
* Current active uncontrolled infection

Where it's running

• Washington University School of Medicine, Program in Physical Therapy
  St Louis, Missouri, United States Recruiting

Study contacts

• Study coordinator: Marcie Harris-Hayes, DPT, MSCI
• Email: harrisma@wustl.edu
• Phone: 314-286-1435

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Baricitinib Added to Corticosteroids in PMR (Polymyalgia Rheumatica) May Improve Control

  This study tests whether baricitinib plus low-dose steroids works better than steroids alone for people 50 and older with PMR.

  Recruiting at 19 sites Phase 3 University Hospital, Brest · Aix-en-Provence and 22 other locations · NCT07279688

• Personalized lab test to predict the best treatment for rheumatic diseases

  This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT07150000

• Using PET and MRI scans to improve diagnosis and treatment of polymyalgia rheumatica

  This project will try combined PET/CT and PET/MRI scans to see if they improve diagnosis and treatment choices for people over 50 with suspected polymyalgia rheumatica.

  Recruiting at 2 sites Aarhus University Hospital · Aarhus and 6 other locations · NCT07010484

• Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases

  This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT06696027

• Evaluating Thrombomodulin for Ruling Out Giant Cell Arteritis in Patients with Polymyalgia Rheumatica

  This study is testing if a blood marker called thrombomodulin can help doctors tell if older patients with polymyalgia rheumatica also have giant cell arteritis.

  Recruiting Centre Hospitalier Universitaire Dijon · Dijon · NCT06609668

• Exploring factors that predict treatment response in patients with polymyalgia rheumatica and giant cell arteritis

  This study is trying to find out what factors help predict how well new patients with polymyalgia rheumatica and giant cell arteritis will respond to steroid treatment.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT05479448

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.